Literature DB >> 10671349

Shiga toxin-producing Escherichia coli urinary tract infection associated with hemolytic-uremic syndrome in an adult and possible adverse effect of ofloxacin therapy.

M Miedouge1, J Hacini, F Grimont, J Watine.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10671349     DOI: 10.1086/313668

Source DB:  PubMed          Journal:  Clin Infect Dis        ISSN: 1058-4838            Impact factor:   9.079


× No keyword cloud information.
  3 in total

1.  Hemolytic-uremic syndrome after Escherichia coli urinary tract infection in humans: systematic review of the literature.

Authors:  Dejan Lavrek; Sebastiano A G Lava; Gregorio P Milani; Giacomo D Simonetti; Mario G Bianchetti; Olivier Giannini
Journal:  J Nephrol       Date:  2018-10-17       Impact factor: 3.902

2.  Analysis of urinary Escherichia coli isolates for ability to produce Shiga toxin.

Authors:  James R Johnson; Catherine Jerome; Daniel R Boster; Ann E Stapleton; Phillip I Tarr
Journal:  J Clin Microbiol       Date:  2002-06       Impact factor: 5.948

Review 3.  Renal and neurological involvement in typical Shiga toxin-associated HUS.

Authors:  Howard Trachtman; Catherine Austin; Maria Lewinski; Rolf A K Stahl
Journal:  Nat Rev Nephrol       Date:  2012-09-18       Impact factor: 28.314

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.